REFERENCES
1. International drug monitoring: the role of national centres. Report of a WHO meeting. World Health Organ Tech Rep Ser. 1972; 498:1–25.
2. Rebelo Gomes E, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy. 2008; 38:191–8.
3. Na HR, Lee JM, Jung JW, Lee SY. Usefulness of drug provocation tests in children with a history of adverse drug reaction. Korean J Pediatr. 2011; 54:304–9.
4. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hyper-sensitivity. Allergy. 2002; 57:45–51.
5. Barbaud A, Gonçalo M, Bruynzeel D, Bircher A. European Society of Contact Dermatitis. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis. 2001; 45:321–8.
6. Yang MS, Ban GY, Kim MH, Lim KH, Kwon HS, Song WJ, et al. KAAA-CI Standardization Committee Report on the procedures and applica-tions of the diagnostic tests for drug allergy. Allergy Asthma Respir Dis. 2017; 5:239–47.
7. Soyer O, Sahiner UM, Sekerel BE. Pro and contra: provocation tests in drug hypersensitivity. Int J Mol Sci 2017 Jul 4;18(7). pii: E1437.https://doi.org/10.3390/ijms18071437.
9. Park GM, Seo JH, Kim HY, Yu JH, Hong SJ. Four cases of drug allergy caused by non-steroidal anti-inflammatory drugs in children. Pediatr Allergy Respir Dis. 2011; 21:344–9.
10. Choi J, Lee JY, Kim KH, Choi J, Ahn K, Kim J. Evaluation of drug provocation tests in Korean children: a single center experience. Asian Pac J Allergy Immunol. 2016; 34:130–6.
11. Noh SR, Yoon J, Cho HJ, Song S, Park GM, Yu J, et al. Outcomes of drug provocation test in Korean children with suspected drug hypersensitivity reaction. Allergy Asthma Respir Dis. 2017; 6:26–33.